Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12
Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 is a medicine authorised by Swissmedic under authorisation number 67602. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 August 2020 and the authorisation is valid without a time limit. ATC code C09DX03 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 67602 |
|---|---|
| Name | Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 |
| Full name | Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX03 |
| First authorisation | 11 August 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg, Filmtabletten | B | 11 August 2020 |
| 2 | Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg, Filmtabletten | B | 11 August 2020 |
| 3 | Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/12,5 mg, Filmtabletten | B | 11 August 2020 |
| 4 | Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/25 mg, Filmtabletten | B | 11 August 2020 |
| 5 | Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/25 mg, Filmtabletten | B | 11 August 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 2 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 3 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 5 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 6 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 7 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 9 | 28 | Tablette(n) | C09DX03 | 02.07.2. | B |
| 10 | 98 | Tablette(n) | C09DX03 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 authorised in Switzerland?
Yes. Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 is authorised by Swissmedic under authorisation number 67602, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 have?
Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.